fashion -WSS

fashion

author：leisure time 2025-09-07 21:56:33 - browse：757

Neurocrine Biosciences decided to join PhRMA. Adobe

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Some dementia cases could be undiagnosed liver disease

WSS

Who gets to use the title 'doctor'?

Novo Nordisk to expand supply of Wegovy for U.S. patients

The new HIV moral panic

Involuntary treatment for addiction doesn't work

Woman gored by Bison at Yellowstone

Vertex non

entertainment

fashion

knowledge

23andMe had bad news about my health. I wish a person had delivered it

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Walensky prepares to leave CDC — and Congress — behind

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Bright Health sells Medicare Advantage business to Molina

Apple Vision Pro: A first look at health apps on the new VR headset

Medical leaders decry Supreme Court decision on affirmative action

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Heart attack and stroke risk calculators need revising

Juul spent big to court Black leaders to promote its e

focus

Georgia court denies Trump's request to quash DA's 2020 election probe

New Ultima Genomics DNA sequencer can read genome for $100

SAMSHA loosens regulations on methadone treatment centers

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Grail faces three suits alleging harassment, retaliation

entertainment

knowledge

hotspot

focus